Sai Life Sciences has submitted a certificate under relevant regulations for the quarter ended September 30, 2025. The certificate, provided by KFin Technologies, confirms the details of securities dematerialized/rematerialized during the period. This information has been furnished to all stock exchanges where Sai Life Sciences’ shares are listed, ensuring compliance.
Regulatory Compliance Update
Sai Life Sciences has officially announced the submission of a certificate pertaining to depository and participant regulations. This submission covers the fiscal quarter ending September 30, 2025, reflecting the company’s commitment to adhering to regulatory standards.
Details of Certification
The certificate, dated October 2, 2025, was received from KFin Technologies Limited, the Registrar and Share Transfer Agent (RTA) for Sai Life Sciences. This document confirms the details of all securities dematerialized and rematerialized during Q2 2026.
Confirmation of Information Dissemination
As per the official statement, the information contained within the certificate has been duly provided to all relevant stock exchanges on which Sai Life Sciences maintains a listing. This ensures transparency and availability of key information to investors and stakeholders.
Source: BSE
